BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 10831341)

  • 1. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvaginal sonography as a screening method for the detection of early ovarian cancer.
    DePriest PD; Gallion HH; Pavlik EJ; Kryscio RJ; van Nagell JR
    Gynecol Oncol; 1997 Jun; 65(3):408-14. PubMed ID: 9190966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened.
    van Nagell JR; DePriest PD; Ueland FR; DeSimone CP; Cooper AL; McDonald JM; Pavlik EJ; Kryscio RJ
    Cancer; 2007 May; 109(9):1887-96. PubMed ID: 17373668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer screening in asymptomatic postmenopausal women.
    DePriest PD; van Nagell JR; Gallion HH; Shenson D; Hunter JE; Andrews SJ; Powell DE; Pavlik EJ
    Gynecol Oncol; 1993 Nov; 51(2):205-9. PubMed ID: 8276295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer screening.
    van Nagell JR; Gallion HH; Pavlik EJ; DePriest PD
    Cancer; 1995 Nov; 76(10 Suppl):2086-91. PubMed ID: 8635005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography.
    Van Nagell JR; DePriest PD; Puls LE; Donaldson ES; Gallion HH; Pavlik EJ; Powell DE; Kryscio RJ
    Cancer; 1991 Aug; 68(3):458-62. PubMed ID: 2065264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
    Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
    Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.
    Tailor A; Bourne TH; Campbell S; Okokon E; Dew T; Collins WP
    Ultrasound Obstet Gynecol; 2003 Apr; 21(4):378-85. PubMed ID: 12704748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The malignant potential of small cystic ovarian tumors in women over 50 years of age.
    Bailey CL; Ueland FR; Land GL; DePriest PD; Gallion HH; Kryscio RJ; van Nagell JR
    Gynecol Oncol; 1998 Apr; 69(1):3-7. PubMed ID: 9570990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
    Rosenthal AN; Fraser LSM; Philpott S; Manchanda R; Burnell M; Badman P; Hadwin R; Rizzuto I; Benjamin E; Singh N; Evans DG; Eccles DM; Ryan A; Liston R; Dawnay A; Ford J; Gunu R; Mackay J; Skates SJ; Menon U; Jacobs IJ;
    J Clin Oncol; 2017 May; 35(13):1411-1420. PubMed ID: 28240969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer screening.
    van Nagell JR; DePriest PD; Gallion HH; Pavlik EJ
    Cancer; 1993 Feb; 71(4 Suppl):1523-8. PubMed ID: 8431889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.
    Vuento MH; Pirhonen JP; Mäkinen JI; Laippala PJ; Grönroos M; Salmi TA
    Cancer; 1995 Oct; 76(7):1214-8. PubMed ID: 8630900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
    Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
    Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to decrease false-positive cases of ovarian cancer screening by transvaginal sonography.
    Misawa T; Asai M; Higashide K
    J Exp Clin Cancer Res; 1997 Jun; 16(2):217-20. PubMed ID: 9261750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound screening for the early detection of ovarian cancer.
    DePriest PD; DeSimone CP
    J Clin Oncol; 2003 May; 21(10 Suppl):194s-199s. PubMed ID: 12743134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.
    Menon U; Skates SJ; Lewis S; Rosenthal AN; Rufford B; Sibley K; Macdonald N; Dawnay A; Jeyarajah A; Bast RC; Oram D; Jacobs IJ
    J Clin Oncol; 2005 Nov; 23(31):7919-26. PubMed ID: 16258091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
    Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
    Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy.
    Pavlik EJ; Saunders BA; Doran S; McHugh KW; Ueland FR; Desimone CP; Depriest PD; Ware RA; Kryscio RJ; van Nagell JR
    Cancer; 2009 Aug; 115(16):3689-98. PubMed ID: 19603478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.